SERPINC1 and acute respiratory failure: However, these previous studies were only conducted in patients with acute respiratory failure who underwent venovenous ECMO; thus, future trials are necessary to confirm the effect of AT III supplementation on clinical outcomes in patients with circulatory failure who underwent venoarterial ECMO.